Facility Design Solutions

  1. Ibex™ Dedicate
    6/13/2019

    As the biopharma industry identifies faster and more efficient ways to deliver drugs to patients, such as break-through and fast track designations for accelerated approval, these progresses create pressure on both large and small drug manufacturers. As development timelines shorten, decisions related to drug commercialization need to be taken earlier, when key results are not yet available. And deciding on the scale and type of facility to build without complete data can create substantial risks with costly consequences.

  2. GE Life Sciences Overview - Cell Processing
    8/30/2018

    Helping your cell therapies succeed through our reach and resources.

  3. Genderless AseptiQuik® L Series Connectors
    5/15/2018

    Genderless AseptiQuik® L Connectors enable quick and easy sterile connections, in large-volume, high-flow production environments. The largeformat, 3/4" and 1" genderless design simplifies system integration and minimizes the risk of operator error. The connectors’ robust construction provides reliable performance without the need for clamps, fixtures or tube welders. Biopharmaceutical manufacturers benefit from interchangeable 3/4” and 1” flow solutions for full-scale bioprocessing production environments with the quality and market availability they expect from the leader in single-use connection technology.

  4. Genderless AseptiQuik® L Series Connectors Datasheet
    5/15/2018

    Genderless AseptiQuik® L Connectors enable quick and easy sterile connections, in large-volume, high-flow production environments. The largeformat, 3/4" and 1" genderless design simplifies system integration and minimizes the risk of operator error.

  5. Cleanroom PODs® with LifeAire Systems
    10/5/2017

    PODs coupled with LifeAire Systems’ purification technology offers extreme cleanliness and stability of the air in G-CON‘s prefabricated cleanrooms. This is achieved with LifeAire’s proven and patented multi-stage filtration systems built within the POD, eliminating all toxic airborne pathogens within critical space environments on a single pass. LifeAire’s new, transformational and proven technology provides deliverables that exceed GMP metrics that have been recognized as toxic to living cell culture.

  6. PODs® For Assay, Analytical And Microbial Labs
    10/5/2017

    G-CON’s LabPODs provide the most comprehensive, flexible and scalable containment solutions for laboratory needs. Our highly experienced team will work together with you to achieve the ideal cleanroom solution, which exceeds traditional infrastructures in technical advantages and value creation, making the legacy cost per sq. ft. analysis irrelevant.

  7. PODs® For Cell Therapy & Regenerative Medicine
    10/5/2017

    G-CON’s Cell Therapy PODs® provide the most comprehensive, flexible and podular processing solutions for the personalized and regenerative healthcare industries. Our highly experienced team will work together with you to achieve the ideal cleanroom solution, which exceeds traditional infrastructures in technical advantages and value creation, making the legacy cost per sq. ft. analysis irrelevant.

  8. Cost Comparison Of Cleanroom Designs
    10/5/2017

    The 2 X 2,000L Sweet Spot is a highly sought after production capacity. So we commissioned a study of the three main facility approaches to determine the overall project ROI for each. The most critical factor was not cost per square foot but SPEED.

  9. Trends Of Modular Mobile Cleanrooms
    10/5/2017

    Prefabricated cleanrooms enable production of biopharmaceuticals and cell and gene therapies at lower capital cost than traditional fixed facilities. Prefabricated cleanrooms can provide a standardized manufacturing platform that is readily deployable across the globe allowing customers to save time and cost. Reducing the size of processes and facilities allow the prefabricated approach to provide effective delivery of all therapies, including low volume therapies, through multiple regional production sites.

  10. Transformations In Biomanufacturing
    8/15/2016

    In biomanufacturing the only certainty is risk and the only constant is change. Technology is pushing new frontiers, new markets are opening up across the globe, and new competition is creating new levels of urgency—all under the ever more watchful eye of regulators.